Oral contraceptives and stroke: Foes or friends

Front Neuroendocrinol. 2022 Oct:67:101016. doi: 10.1016/j.yfrne.2022.101016. Epub 2022 Jul 20.

Abstract

Incidents of strokes are increased in young women relative to young men, suggesting that oral contraceptive (OC) use is one of the causes of stroke among young women. Long-term exposures to the varying combinations of estrogen and progestogen found in OCs affect blood clotting, lipid and lipoprotein metabolism, endothelial function, and de novo synthesis of neurosteroids, especially brain-derived 17β-estradiol. The latter is essential for neuroprotection, memory, sexual differentiation, synaptic transmission, and behavior. Deleterious effects of OCs may be exacerbated due to comorbidities like polycystic ovary syndrome, sickle cell anemia, COVID-19, exposures to endocrine disrupting chemicals, and conventional or electronic cigarette smoking. The goal of the current review is to revisit the available literature regarding the impact of OC use on stroke, to explain possible underlying mechanisms, and to identify gaps in our understanding to promote future research to reduce and cure stroke in OC users.

Keywords: Arterial thromboembolism; COVID-19; Cigarette smoking; Polycystic ovary syndrome; Stroke; Transgender; Venous thromboembolism.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Contraceptives, Oral / pharmacology
  • Electronic Nicotine Delivery Systems*
  • Female
  • Friends
  • Humans
  • Male
  • Stroke* / etiology

Substances

  • Contraceptives, Oral